Keywords: mmi, 1st-half, loss, up, admin, costs, uk
MMI's 1st-half loss up 12% on admin costs
Article | 03 December 2007
UK pharmaceutical developer Medical Marketing International's loss for the six months ended September 30, 2007, was L1.9 million ($3.9 million), up 11.8% on the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Takeda debuts three new diabetes drugs, Nesina, Kazano and Oseni, in USA
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- It's official: "obesity is a disease," says AMA
- Mixed results for AstraZeneca/B-MS' Onglyza; Newron's safinamide does well in PD
